GCGR
-
NASDAQ-listed companies are looking for obesity drugs with the potential for weight loss and muscle gain
If your company is interested in this opportunity, please contact the DrugTimes BD team as soon as possible!
-
与韩美公司合作，默沙东NASH研发管线再添新员
2020年8月4日，默沙东（MSD）和韩美（Hanmi Pharmaceutical）共同宣布，两家公司已经就用于治疗非酒精性脂肪性肝炎（NASH）的efinopegdutide（…
